Correction: Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.

Allergy Asthma Clin Immunol

Medical Department, Sanofi Consumer Healthcare, AI, Traira 456, Santana de Parnaiba, SP, 06540 365, Brazil.

Published: December 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793548PMC
http://dx.doi.org/10.1186/s13223-022-00754-3DOI Listing

Publication Analysis

Top Keywords

correction fexofenadine
4
fexofenadine review
4
review safety
4
safety efficacy
4
efficacy unmet
4
unmet children
4
children allergic
4
allergic rhinitis
4
correction
1
review
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!